Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis - Wikidata - wikimedia - TriplyDB

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis

http://www.wikidata.org/entity/Q37609624

about

The role of T and B cells in human atherosclerosis and atherothrombosis ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis."Attack of the Clones": Commonalities Between Cancer and Atherosclerosis.Vascular Smooth Muscle Cells in Atherosclerosis.Deficient CDKN2B Expression: A Double Hit for PAD.Calreticulin Regulates Neointima Formation and Collagen Deposition following Carotid Artery Ligation.The role of necroptosis in atherosclerotic disease.The Role of Efferocytosis in Atherosclerosis.The genetic basis of peripheral arterial disease: current knowledge, challenges, and future directions.CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels Integrative functional genomics identifies regulatory mechanisms at coronary artery disease loci.CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis.CDKN2B expression and subcutaneous adipose tissue expandability: possible influence of the 9p21 atherosclerosis locus Experimental Biology for the Identification of Causal Pathways in Atherosclerosis.Genetics and Genomics of Coronary Artery Disease.Eating the Dead to Keep Atherosclerosis at Bay.Monocytes and macrophages in abdominal aortic aneurysm.Cell Death in the Vessel Wall: The Good, the Bad, the Ugly.In the beginning and at the end: calreticulin.Heart disease: Death-defying plaque cells.Acute CD47 Blockade During Ischemic Myocardial Reperfusion Enhances Phagocytosis-Associated Cardiac Repair Reconciling Smooth Muscle Cell Oligoclonality and Proliferative Capacity in Experimental Atherosclerosis.CDKN2A and CDKN2B methylation in coronary heart disease cases and controls.Mechanisms and Consequences of Defective Efferocytosis in Atherosclerosis.Loss of CDKN2B Promotes Fibrosis via Increased Fibroblast Differentiation Rather Than Proliferation.Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Atherosclerosis by Affecting Foam Cell Formation and Efferocytosis.Roles of the Chr.9p21.3 ANRIL Locus in Regulating Inflammation and Implications for Anti-Inflammatory Drug Target Identification.Translating GWAS Findings to Novel Therapeutic Targets for Coronary Artery Disease.Gene expression signatures, pathways and networks in carotid atherosclerosis Complex genetics of female fertility Long Noncoding RNA : Lnc-ing Genetic Variation at the Chromosome 9p21 Locus to Molecular Mechanisms of Atherosclerosis

P2860

Q27000791-3EFCA200-13A8-49B6-9ADE-8901069C610E Q27330207-0FA3BDD8-DBAE-41AA-90BE-A03B7C66B668 Q30274746-A4F4B86E-7D44-4A77-A283-3978EBF543C6 Q30277316-E3BFB61D-161E-4592-8C32-4C544C44E5EC Q30277622-A8160725-57DA-48AA-9578-48AFEB8F38D3 Q30362674-75B22A0C-F8F6-474B-B0BD-8719638940BF Q33643471-96EA6C76-6C5E-4444-B5AC-A9451BDA1C84 Q34680660-EE17636A-BFD4-4274-A786-D0E29FCE271D Q35540524-81E561D6-0169-47F9-9960-59A1264623EF Q36540680-E0AB46D8-9E22-4E78-A8E6-D096DFE39464 Q37085518-825B2043-4510-4B29-9374-DCD34572AB47 Q37165792-E077F72D-69B0-4B39-8C4A-B37D473932F3 Q37729911-D2BB99B9-487F-4ED0-AFE2-0E5B702AECB9 Q38723704-7ABD8B7A-6159-40EC-AE8C-47833CE25647 Q38944185-F9005D7D-F942-46FF-96C9-2B3461DF9FE2 Q39134393-01DD6419-9D9A-4D97-8F2A-0D2F62A67C98 Q39239967-876327C6-F1E4-447C-8FCF-18113AD4F291 Q39388843-3E67394F-6236-426F-881D-406A6913E18E Q42030457-094A8E12-0E58-421C-8804-AB7857EFD12D Q42173660-541468D8-648E-449C-8CBD-A910D6FEB24E Q42357842-4D0181BD-E1A8-464E-B6CA-9906F0060028 Q45048571-282F08BE-2788-427B-AA45-3F172E2BE7BD Q47108489-B3F7C6AF-E6EB-40E8-B495-DA8DA1414697 Q49318594-07A0958C-5A0A-4983-AD94-6857C2904F95 Q50116500-BB120F28-09A5-4210-B837-611EAB24E6AE Q50222895-D3BA2EA7-EFC1-4050-986C-6EED87ED0FE3 Q55078607-2057BF66-B0A1-4D69-92A3-ADF72CAB55BD Q55175982-17B45050-950F-457C-95A7-B796657BAA90 Q57315819-2769F6A7-EC01-4647-9E6C-1C929767C6CA Q57560926-C49B6BEF-E3DC-4B52-BB81-60E0C1291DB5 Q59128283-7CFE8687-5E80-4EE1-93AB-1EAD3155158F

P2860

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis

http://www.wikidata.org/entity/Q37609624

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis

@en

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.

@nl

type

label

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis

@en

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.

@nl

prefLabel

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis

@en

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis.

@nl

P1433

Q37609624-6F17C8CC-8BBB-4BEB-AE39-971B044A3B98

P1476

Q37609624-B855097E-3BA3-4F72-BEC1-C1B17304A5C3

P2093

Q37609624-012D08D7-6598-475F-A916-804CFF2D4E1F

Q37609624-10BDDE29-A164-4377-AAC2-1A872E4F4DE4

Q37609624-121910A8-A713-40CF-8C1B-F2DF07648890

Q37609624-3DD0CD6F-38FF-4703-82D4-A74D2DD4A58D

Q37609624-7A0E5E4D-BAFB-49A2-9638-C137042EA1AF

Q37609624-7FC8A6DC-18F2-4A07-85C4-059825627585

Q37609624-8D6C3847-A9BF-4019-9F2E-A64737684997

Q37609624-BBB01B6C-13B1-40DF-BB04-CFFE8E9169A9

Q37609624-CE6DBB4D-B856-4F02-9184-C2DA6796E9AC

Q37609624-EBA66E8E-D1D0-4405-BF6C-AC5601F5E9D6

P2860

Q37609624-0A3C8D68-AC65-4AEE-8ED2-AE6D4719F21D

Q37609624-182844C6-BE29-43AE-A5DA-B9E76F11D8DB

Q37609624-1D511668-4C1F-4311-9656-EEBFA3684D5B

Q37609624-23BF8669-36A2-4F43-8E5C-2725C7B426D0

Q37609624-251E704F-89CA-49A5-A139-2B3B941EFF26

Q37609624-26FC6D51-B9B8-47F1-B93A-B6848624AB07

Q37609624-32848FEB-2E46-4FFB-801F-070E13898484

Q37609624-34549C3A-B96C-4172-AAF8-D8BC68E6DE63

Q37609624-35FC71F1-7582-4FAE-981D-5C57D22E21AD

Q37609624-39A292E4-BFEC-4B93-AB82-039C4B56AEA1

P304

Q37609624-B6FA1FED-2405-4969-ADDE-2C4E555336BF

P31

Q37609624-D31D74E1-4D52-4A93-8074-2B02D1C26D4B

P356

Q37609624-0FD31224-815D-49EE-8886-85A204D00FC7

P407

Q37609624-359D4398-6905-465E-8359-435ECA18FD60

P433

Q37609624-02082501-CA05-4737-B810-810AC177A06E

P478

Q37609624-44269246-7EB2-40D9-B207-4E73F6514847

P50

Q37609624-003F80EB-6AE7-4C1A-9ECE-87A2B19ECDAC

Q37609624-86CE5296-6170-47B5-8320-EC75BD45CA6A

P577

Q37609624-D76ECEF2-DF70-4D2F-A8CF-F44DE586944E

P5875

Q37609624-81151F52-97E0-4A71-AEE3-B621E8145F11

P698

Q37609624-3A111B38-944D-4384-8755-34D4C6878A41

P921

Q37609624-90168598-B325-48A0-9290-3CB4EBFD361C

P932

Q37609624-BA276008-663A-4D97-BFC7-3E500C22713C

P356

P1433

Journal of Clinical Investigation

P1476

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis

@en

P2093

Clint Miller

http://www.w3.org/2001/XMLSchema#string

Eric Schadt

http://www.w3.org/2001/XMLSchema#string

Frederick Dewey

http://www.w3.org/2001/XMLSchema#string

Hope Lancero

http://www.w3.org/2001/XMLSchema#string

Kelly Downing

http://www.w3.org/2001/XMLSchema#string

Ljubica Perisic

http://www.w3.org/2001/XMLSchema#string

Nicholas J Leeper

http://www.w3.org/2001/XMLSchema#string

Ramendra Kundu

http://www.w3.org/2001/XMLSchema#string

Tom Quertermous

http://www.w3.org/2001/XMLSchema#string

Uwe Raaz

http://www.w3.org/2001/XMLSchema#string

P2860

Chromosome 9p21 SNPs Associated with Multiple Disease Phenotypes Correlate with ANRIL Expression

INK4/ARF transcript expression is associated with chromosome 9p21 variants linked to atherosclerosis

p19(ARF) deficiency reduces macrophage and vascular smooth muscle cell apoptosis and aggravates atherosclerosis

Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47

Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies.

Metabolic connections during apoptotic cell engulfment.

MicroRNA-26a is a novel regulator of vascular smooth muscle cell function

A common allele on chromosome 9 associated with coronary heart disease

Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis

Effect of 9p21.3 coronary artery disease locus neighboring genes on atherosclerosis in mice

P304

1083-1097

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI70391

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

Lars Maegdefessel

P577

2014-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260219032

http://www.w3.org/2001/XMLSchema#string

P698

24531546

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3938254

http://www.w3.org/2001/XMLSchema#string